JONATHAN COUCHMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN COUCHMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN COUCHMAN. JONATHAN COUCHMAN is 10% Owner in ENZON PHARMACEUTICALS, INC. ($ENZN) and 10% Owner in Myrexis, Inc. ($MYRX).
Latest Insider Trading Transactions of JONATHAN COUCHMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 26 2020 | MYRX | Myrexis, Inc. | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.19 | 25,000 | 4,783 | 1,590,194 | 1.6 M to 1.6 M (-1.55 %) |
Aug 26 2020 | MYRX | Myrexis, Inc. | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.18 | 52,100 | 9,555 | 1,615,194 | 1.7 M to 1.6 M (-3.12 %) |
Aug 26 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.19 | 25,000 | 4,783 | 1,590,194 | 1.6 M to 1.6 M (-1.55 %) |
Aug 26 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.18 | 52,100 | 9,555 | 1,615,194 | 1.7 M to 1.6 M (-3.12 %) |
Aug 06 2020 | MYRX | Myrexis, Inc. | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.20 | 506,292 | 101,258 | 2,100,524 | 1.6 M to 2.1 M (+31.76 %) |
Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 160,785 | 22,510 | 633,264 | 472.5 K to 633.3 K (+34.03 %) |
Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 469,551 | 65,737 | 472,479 | 2.9 K to 472.5 K (+16,036.58 %) |
Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 2,678 | 375 | 2,928 | 250 to 2.9 K (+1,071.20 %) |
Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 19,709 | 2,661 | 1,594,232 | 1.6 M to 1.6 M (+1.25 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 1,574,523 | 1.6 M to 1.6 M (+0.32 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 1,569,523 | 1.6 M to 1.6 M (+0.64 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,717,666 | 4.7 M to 4.7 M (+0.21 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 500 | 125 | 4,707,666 | 4.7 M to 4.7 M (+0.01 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,707,166 | 4.7 M to 4.7 M (+0.21 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 15,500 | 3,875 | 4,697,166 | 4.7 M to 4.7 M (+0.33 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 1,574,523 | 1.6 M to 1.6 M (+0.32 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 1,569,523 | 1.6 M to 1.6 M (+0.64 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,717,666 | 4.7 M to 4.7 M (+0.21 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 500 | 125 | 4,707,666 | 4.7 M to 4.7 M (+0.01 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,707,166 | 4.7 M to 4.7 M (+0.21 %) |
Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 15,500 | 3,875 | 4,697,166 | 4.7 M to 4.7 M (+0.33 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 510 | 4,681,666 | 4.7 M to 4.7 M (+0.04 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,500 | 638 | 4,679,666 | 4.7 M to 4.7 M (+0.05 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,500 | 1,148 | 4,677,166 | 4.7 M to 4.7 M (+0.10 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.27 | 312,523 | 84,100 | 1,559,523 | 1.2 M to 1.6 M (+25.06 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.24 | 213,189 | 50,419 | 1,247,000 | 1 M to 1.2 M (+20.62 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.23 | 15,261 | 3,510 | 1,033,811 | 1 M to 1 M (+1.50 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 2,500 | 550 | 1,018,550 | 1 M to 1 M (+0.25 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 1,100 | 242 | 1,016,050 | 1 M to 1 M (+0.11 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 450 | 99 | 1,014,950 | 1 M to 1 M (+0.04 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 42,450 | 9,339 | 1,014,500 | 972.1 K to 1 M (+4.37 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 40,050 | 8,811 | 972,050 | 932 K to 972.1 K (+4.30 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 15,000 | 3,294 | 932,000 | 917 K to 932 K (+1.64 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 2,500 | 525 | 917,000 | 914.5 K to 917 K (+0.27 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 914,500 | 814.5 K to 914.5 K (+12.28 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 814,500 | 714.5 K to 814.5 K (+14.00 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 67,200 | 17,472 | 4,672,666 | 4.6 M to 4.7 M (+1.46 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,800 | 2,277 | 4,605,466 | 4.6 M to 4.6 M (+0.19 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,600 | 5,253 | 4,596,666 | 4.6 M to 4.6 M (+0.45 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,671 | 936 | 4,576,066 | 4.6 M to 4.6 M (+0.08 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 384,100 | 98,906 | 4,572,395 | 4.2 M to 4.6 M (+9.17 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 9,500 | 2,470 | 4,188,295 | 4.2 M to 4.2 M (+0.23 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 40,316 | 10,482 | 4,178,795 | 4.1 M to 4.2 M (+0.97 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,255 | 2,146 | 4,138,479 | 4.1 M to 4.1 M (+0.20 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 112 | 29 | 4,130,224 | 4.1 M to 4.1 M (0.00 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 26,655 | 6,930 | 4,130,112 | 4.1 M to 4.1 M (+0.65 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 11,368 | 2,956 | 4,103,457 | 4.1 M to 4.1 M (+0.28 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 355 | 92 | 4,092,089 | 4.1 M to 4.1 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 635 | 165 | 4,091,734 | 4.1 M to 4.1 M (+0.02 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,800 | 728 | 4,091,099 | 4.1 M to 4.1 M (+0.07 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 21,975 | 5,714 | 4,088,299 | 4.1 M to 4.1 M (+0.54 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,000 | 5,200 | 4,066,324 | 4 M to 4.1 M (+0.49 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 600 | 156 | 4,046,324 | 4 M to 4 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,300 | 338 | 4,045,724 | 4 M to 4 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 32,345 | 8,410 | 4,044,424 | 4 M to 4 M (+0.81 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,120 | 291 | 4,012,079 | 4 M to 4 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 500 | 130 | 4,010,959 | 4 M to 4 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 68,195 | 17,731 | 4,010,459 | 3.9 M to 4 M (+1.73 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 520 | 3,942,264 | 3.9 M to 3.9 M (+0.05 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 510 | 4,681,666 | 4.7 M to 4.7 M (+0.04 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,000 | 260 | 3,940,264 | 3.9 M to 3.9 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,500 | 638 | 4,679,666 | 4.7 M to 4.7 M (+0.05 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 5,500 | 1,430 | 3,939,264 | 3.9 M to 3.9 M (+0.14 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,500 | 1,148 | 4,677,166 | 4.7 M to 4.7 M (+0.10 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 50,000 | 13,000 | 3,933,764 | 3.9 M to 3.9 M (+1.29 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.27 | 312,523 | 84,100 | 1,559,523 | 1.2 M to 1.6 M (+25.06 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,200 | 5,252 | 3,883,764 | 3.9 M to 3.9 M (+0.52 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.24 | 213,189 | 50,419 | 1,247,000 | 1 M to 1.2 M (+20.62 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,000 | 1,040 | 3,863,564 | 3.9 M to 3.9 M (+0.10 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.23 | 15,261 | 3,510 | 1,033,811 | 1 M to 1 M (+1.50 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 55,000 | 14,300 | 3,859,564 | 3.8 M to 3.9 M (+1.45 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 2,500 | 550 | 1,018,550 | 1 M to 1 M (+0.25 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 33,500 | 8,710 | 3,804,564 | 3.8 M to 3.8 M (+0.89 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 1,100 | 242 | 1,016,050 | 1 M to 1 M (+0.11 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,000 | 780 | 3,771,064 | 3.8 M to 3.8 M (+0.08 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 450 | 99 | 1,014,950 | 1 M to 1 M (+0.04 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 185,700 | 48,282 | 3,768,064 | 3.6 M to 3.8 M (+5.18 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 42,450 | 9,339 | 1,014,500 | 972.1 K to 1 M (+4.37 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,700 | 1,222 | 3,582,364 | 3.6 M to 3.6 M (+0.13 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 40,050 | 8,811 | 972,050 | 932 K to 972.1 K (+4.30 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 15,000 | 3,294 | 932,000 | 917 K to 932 K (+1.64 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 2,500 | 525 | 917,000 | 914.5 K to 917 K (+0.27 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 914,500 | 814.5 K to 914.5 K (+12.28 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 814,500 | 714.5 K to 814.5 K (+14.00 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 67,200 | 17,472 | 4,672,666 | 4.6 M to 4.7 M (+1.46 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,800 | 2,277 | 4,605,466 | 4.6 M to 4.6 M (+0.19 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,600 | 5,253 | 4,596,666 | 4.6 M to 4.6 M (+0.45 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,671 | 936 | 4,576,066 | 4.6 M to 4.6 M (+0.08 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 384,100 | 98,906 | 4,572,395 | 4.2 M to 4.6 M (+9.17 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 9,500 | 2,470 | 4,188,295 | 4.2 M to 4.2 M (+0.23 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 40,316 | 10,482 | 4,178,795 | 4.1 M to 4.2 M (+0.97 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,255 | 2,146 | 4,138,479 | 4.1 M to 4.1 M (+0.20 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 112 | 29 | 4,130,224 | 4.1 M to 4.1 M (0.00 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 26,655 | 6,930 | 4,130,112 | 4.1 M to 4.1 M (+0.65 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 11,368 | 2,956 | 4,103,457 | 4.1 M to 4.1 M (+0.28 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 355 | 92 | 4,092,089 | 4.1 M to 4.1 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 635 | 165 | 4,091,734 | 4.1 M to 4.1 M (+0.02 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,800 | 728 | 4,091,099 | 4.1 M to 4.1 M (+0.07 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 21,975 | 5,714 | 4,088,299 | 4.1 M to 4.1 M (+0.54 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,000 | 5,200 | 4,066,324 | 4 M to 4.1 M (+0.49 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 600 | 156 | 4,046,324 | 4 M to 4 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,300 | 338 | 4,045,724 | 4 M to 4 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 32,345 | 8,410 | 4,044,424 | 4 M to 4 M (+0.81 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,120 | 291 | 4,012,079 | 4 M to 4 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 500 | 130 | 4,010,959 | 4 M to 4 M (+0.01 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 68,195 | 17,731 | 4,010,459 | 3.9 M to 4 M (+1.73 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 520 | 3,942,264 | 3.9 M to 3.9 M (+0.05 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,000 | 260 | 3,940,264 | 3.9 M to 3.9 M (+0.03 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 5,500 | 1,430 | 3,939,264 | 3.9 M to 3.9 M (+0.14 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 50,000 | 13,000 | 3,933,764 | 3.9 M to 3.9 M (+1.29 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,200 | 5,252 | 3,883,764 | 3.9 M to 3.9 M (+0.52 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,000 | 1,040 | 3,863,564 | 3.9 M to 3.9 M (+0.10 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 55,000 | 14,300 | 3,859,564 | 3.8 M to 3.9 M (+1.45 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 33,500 | 8,710 | 3,804,564 | 3.8 M to 3.8 M (+0.89 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,000 | 780 | 3,771,064 | 3.8 M to 3.8 M (+0.08 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 185,700 | 48,282 | 3,768,064 | 3.6 M to 3.8 M (+5.18 %) |
Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,700 | 1,222 | 3,582,364 | 3.6 M to 3.6 M (+0.13 %) |
Page: 1